Literature DB >> 11142494

A fatal case of cholestatic liver failure probably related to gemcitabine.

D C Coeman, E K Verbeken, K L Nackaerts, M G Demedts, J F Vansteenkiste.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11142494     DOI： 10.1023/a:1026514527313

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Severe cholestatic liver failure associated with gemcitabine adjuvant monotherapy for pancreatic cancer.

Authors:  Takaho Okada; Shinichi Egawa; Fuyuhiko Motoi; Kuniharu Yamamoto; Shigeru Ottomo; Naoaki Sakata; Toshiki Rikiyama; Yu Katayose; Michiaki Unno
Journal:  Clin J Gastroenterol       Date:  2011-10-01

2.  Acute liver failure secondary to gemcitabine.

Authors:  Alice Stellman; Mei Mei Loke; Steven Mann
Journal:  BMJ Case Rep       Date:  2010-04-22

3.  A fatal case of progressive steatohepatitis, possibly chemotherapy-associated steatohepatitis related to gemcitabine.

Authors:  Xiang Shan Ren; Kenichi Harada; Seiichi Yoshikawa; Saya Igarashi; Takeshi Urabe; Shinya Yamada; Kazuyoshi Katayanagi; Hiroshi Kurumaya; Yasuni Nakanuma
Journal:  Clin J Gastroenterol       Date:  2010-06-22

4.  Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.

Authors:  Karlijn Verkerk; Hans-Martin Otten; Alwin D R Huitema
Journal:  Cancer Chemother Pharmacol       Date:  2022-09-20       Impact factor: 3.288

5.  Fatal cholestatic liver failure associated with gemcitabine therapy.

Authors:  Keith Robinson; Louis Lambiase; Jianjun Li; Carmela Monteiro; Michael Schiff
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

6.  Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.

Authors:  Soonmo Peter Kang; Tamar Taddei; Bruce McLennan; Jill Lacy
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

7.  Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer.

Authors:  C Barlow; M Nystrom; C Oesterling; D Fennell; J Ismay; C Gallagher
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.